3/27
07:46 am
apre
Rating for APRE
Medium
Report
Rating for APRE
3/27
07:46 am
apre
Rating for APRE
Medium
Report
Rating for APRE
3/26
11:13 am
apre
Aprea Therapeutics, Inc. (NASDAQ: APRE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Aprea Therapeutics, Inc. (NASDAQ: APRE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.